CY2025023I2 - Νεα αλατα λυσινης παραγωγων 4- ((φαινοξυαλκυλ)θειο)-φαινοξυοξεικου οξεος - Google Patents
Νεα αλατα λυσινης παραγωγων 4- ((φαινοξυαλκυλ)θειο)-φαινοξυοξεικου οξεοςInfo
- Publication number
- CY2025023I2 CY2025023I2 CY2025023C CY2025023C CY2025023I2 CY 2025023 I2 CY2025023 I2 CY 2025023I2 CY 2025023 C CY2025023 C CY 2025023C CY 2025023 C CY2025023 C CY 2025023C CY 2025023 I2 CY2025023 I2 CY 2025023I2
- Authority
- CY
- Cyprus
- Prior art keywords
- phenoxyalkyl
- sulphur
- acid derivatives
- phenoxyacetic acid
- lysine salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C323/18—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/20—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton with singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/56—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
- C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
- C07C321/28—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/08—Acetic acid
- C07C53/10—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
- C07C59/70—Ethers of hydroxy-acetic acid, e.g. substitutes on the ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71713705P | 2005-09-14 | 2005-09-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CY2025023I1 CY2025023I1 (el) | 2026-02-25 |
| CY2025023I2 true CY2025023I2 (el) | 2026-02-25 |
Family
ID=37865545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY2025023C CY2025023I2 (el) | 2005-09-14 | 2025-08-13 | Νεα αλατα λυσινης παραγωγων 4- ((φαινοξυαλκυλ)θειο)-φαινοξυοξεικου οξεος |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US7709682B2 (enExample) |
| EP (1) | EP1937065B1 (enExample) |
| JP (1) | JP5467770B2 (enExample) |
| KR (5) | KR20180079468A (enExample) |
| CN (1) | CN101304656B (enExample) |
| AR (1) | AR058044A1 (enExample) |
| AU (1) | AU2006291006B2 (enExample) |
| BE (1) | BE2025C533I2 (enExample) |
| BR (1) | BRPI0615835B8 (enExample) |
| CA (1) | CA2622722C (enExample) |
| CY (1) | CY2025023I2 (enExample) |
| DK (1) | DK1937065T3 (enExample) |
| ES (1) | ES2535427T3 (enExample) |
| FI (1) | FIC20253005I1 (enExample) |
| FR (1) | FR25C1030I2 (enExample) |
| GT (1) | GT200600420A (enExample) |
| HN (1) | HN2006032171A (enExample) |
| HU (2) | HUE025185T2 (enExample) |
| JO (1) | JO3006B1 (enExample) |
| LT (1) | LTC1937065I2 (enExample) |
| LU (1) | LUC50018I2 (enExample) |
| NL (1) | NL301339I2 (enExample) |
| NZ (1) | NZ566504A (enExample) |
| PE (1) | PE20070434A1 (enExample) |
| PL (1) | PL1937065T3 (enExample) |
| PT (1) | PT1937065E (enExample) |
| SI (1) | SI1937065T1 (enExample) |
| TW (1) | TWI414510B (enExample) |
| UY (1) | UY29791A1 (enExample) |
| WO (1) | WO2007033231A2 (enExample) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2539403C (en) * | 2003-09-19 | 2013-11-19 | Janssen Pharmaceutica N.V. | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| UA87467C2 (xx) * | 2003-09-19 | 2009-07-27 | Янссен Фармацевтика Н.В | 4-((феноксіалкіл)тіо)феноксіоцтова кислота та її аналоги$4-((феноксиалкил)тио)феноксиуксусная кислота и ее аналоги |
| MY147518A (en) * | 2004-09-15 | 2012-12-31 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| JO3006B1 (ar) * | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
| PE20080188A1 (es) * | 2006-04-18 | 2008-03-10 | Janssen Pharmaceutica Nv | Derivados del acido benzoazepin-oxi-acetico como agonistas de ppar-delta usados para aumentar hdl-c, reducir ldl-c y reducir colesterol |
| JP5694941B2 (ja) | 2008-10-17 | 2015-04-01 | シーマベイ セラピューティクス，インコーポレイティド | 小型高密度ｌｄｌ粒子を減少させる方法 |
| KR101813728B1 (ko) | 2009-07-31 | 2017-12-29 | 그뤼넨탈 게엠베하 | 결정화 방법 및 생체이용률 |
| US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
| EP2531200B1 (en) * | 2010-02-06 | 2017-07-12 | Grünenthal GmbH | Crystallization method and bioavailability |
| CN103298469A (zh) | 2010-08-31 | 2013-09-11 | 首尔大学校产学协力财团 | PPARδ激动剂的胎儿重编程的用途 |
| WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
| HK1224186A1 (zh) | 2013-11-20 | 2017-08-18 | Cymabay Therapeutics, Inc. | 纯阖家族型高胆固醇血症的治疗 |
| US20160279085A1 (en) * | 2013-11-20 | 2016-09-29 | Cymabay Therapeutics, Inc. | Treatment of Severe Hyperlipidemia |
| ES2701094T3 (es) | 2014-03-20 | 2019-02-20 | Cymabay Therapeutics Inc | Tratamiento de enfermedades colestáticas intrahepáticas |
| US10272058B2 (en) | 2014-03-20 | 2019-04-30 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| CA2944139C (en) | 2014-04-11 | 2020-11-03 | Cymabay Therapeutics, Inc. | Treatment of nafld and nash |
| CN106470675A (zh) * | 2014-06-26 | 2017-03-01 | 西玛贝医药公司 | 严重高甘油三酯血症的治疗 |
| US20190276405A1 (en) * | 2016-05-16 | 2019-09-12 | Pulmagen Therapeutics (Asthma) Limited | Crystal of quinoline derivative |
| US10512622B2 (en) | 2017-07-14 | 2019-12-24 | Cymabay Therapeutics, Inc. | Treatment of intrahepatic cholestatic diseases |
| JP2020533339A (ja) | 2017-09-13 | 2020-11-19 | ノバルティス アーゲー | Ｆｘｒアゴニストを含む組合せ |
| JP7023371B2 (ja) | 2017-09-26 | 2022-02-21 | サイマベイ・セラピューティクス・インコーポレイテッド | 胆汁うっ滞性そう痒の処置 |
| MX2021005724A (es) | 2018-11-16 | 2021-07-21 | Cymabay Therapeutics Inc | Tratamiento combinado contra nafld y nash. |
| WO2020102351A1 (en) | 2018-11-16 | 2020-05-22 | Cymabay Therapeutics, Inc. | Treatment of obesity and its complications |
| EP4034236A1 (en) | 2019-09-26 | 2022-08-03 | Abionyx Pharma SA | Compounds useful for treating liver diseases |
| US20210145774A1 (en) * | 2019-11-14 | 2021-05-20 | Cymabay Therapeutics, Inc. | Treatment of alcoholic liver disease |
| WO2021097034A1 (en) | 2019-11-14 | 2021-05-20 | Cymabay Therapeutics, Inc. | Seladelpar for use in the treatment of intestinal barrier dysfunction and associated diseases |
| CN119735532A (zh) * | 2019-11-21 | 2025-04-01 | 杭州百诚医药科技股份有限公司 | α-氟代查耳酮类衍生物及其应用 |
| RS65546B1 (sr) | 2021-02-01 | 2024-06-28 | Cymabay Therapeutics Inc | Tretman holangiopatija sa seladelparom |
| WO2022189856A1 (en) | 2021-03-08 | 2022-09-15 | Abionyx Pharma Sa | Compounds useful for treating liver diseases |
| KR20250139304A (ko) | 2023-01-29 | 2025-09-23 | 사이머베이 쎄라퓨틱스, 인코퍼레이티드 | 만성 소양증 피부병의 치료 |
| US20240252499A1 (en) | 2023-01-29 | 2024-08-01 | Cymabay Therapeutics, Inc. | Treatment of uremic pruritus |
| WO2024175026A1 (zh) * | 2023-02-24 | 2024-08-29 | 哈尔滨三联药业股份有限公司 | 含氮杂环类化合物及其医药用途 |
| WO2025072489A2 (en) | 2023-09-27 | 2025-04-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Analogues of n-lactoyl-phenylalanine, methods of synthesis, and methods of use |
| WO2026030533A1 (en) | 2024-07-31 | 2026-02-05 | Cymabay Therapeutics, Inc. | Seladelpar for use in treating liver disease |
| US20260055055A1 (en) * | 2024-07-31 | 2026-02-26 | Cymabay Therapeutics, Inc. | Process for making seladelpar |
| US20260207538A1 (en) | 2024-12-20 | 2026-07-23 | Gilead Sciences, Inc. | Combinations for liver disease |
Family Cites Families (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2460689C3 (de) * | 1974-12-20 | 1980-06-26 | Klinge Pharma Gmbh & Co, 8000 Muenchen | 13-disubstituierte Propanol-(2)-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US4125732A (en) * | 1977-05-06 | 1978-11-14 | American Cyanamid Company | 2-Aryloxy-2-(phenoxyalkoxy)phenyl acetic acid and esters |
| DE3026924A1 (de) | 1980-07-16 | 1982-02-18 | Klinge Pharma GmbH & Co, 8000 München | 1,3-diphenoxypropan-2-ol-derivate sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| DE3028776A1 (de) | 1980-07-29 | 1982-02-25 | Klinge Pharma GmbH & Co, 8000 München | Neue 1,3-diphenoxypropan-2-on-derivate sowie verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| EP0056172B1 (en) | 1981-01-09 | 1985-04-03 | FISONS plc | Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them |
| JPS58177934A (ja) | 1982-04-13 | 1983-10-18 | Takeda Chem Ind Ltd | ベンゾキノン誘導体 |
| ATE22072T1 (de) | 1982-09-30 | 1986-09-15 | Merck Frosst Canada Inc | Leukotrienantagonisten, deren herstellung und diese enthaltende zusammensetzungen. |
| US4820867A (en) * | 1983-04-21 | 1989-04-11 | Merck Frosst Canada, Inc. | Phenoxypropoxy halophenylacetic acids as leukotriene antagonists |
| US4513006A (en) * | 1983-09-26 | 1985-04-23 | Mcneil Lab., Inc. | Anticonvulsant sulfamate derivatives |
| JPS61268651A (ja) | 1985-05-23 | 1986-11-28 | Takeda Chem Ind Ltd | フエニル酢酸誘導体およびその製造法 |
| EP0204349A3 (de) * | 1985-06-01 | 1990-01-03 | Dr. Karl Thomae GmbH | Neue heteroaromatische Aminderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| JPH0714910B2 (ja) * | 1988-12-13 | 1995-02-22 | 塩野義製薬株式会社 | 安定な結晶性の塩およびそれを含有するトロンボキサン受容体拮抗剤 |
| US5487008A (en) * | 1990-04-20 | 1996-01-23 | The Regents Of The University Of Michigan | Method and system for detecting the misfire of a reciprocating internal combustion engine in frequency domain |
| CA2092152A1 (en) * | 1992-03-23 | 1993-09-24 | Azuma Igarashi | Phenoxyacetic acid compounds and medical preparations containing them |
| US5726165A (en) * | 1994-07-29 | 1998-03-10 | Smithkline Beecham P.L.C. | Derivatives of 4-(2-aminoethyl)phenoxymethyl-phosphonic and -phosphinic acid and pharmaceutical and veterinary uses therefor |
| JP2002503202A (ja) | 1996-02-02 | 2002-01-29 | メルク エンド カンパニー インコーポレーテッド | 抗糖尿病薬 |
| CA2244831A1 (en) | 1996-02-02 | 1997-08-07 | John T. Olson | Method of treating diabetes and related disease states |
| JP3268242B2 (ja) | 1996-11-14 | 2002-03-25 | 三共株式会社 | 縮合複素環化合物を含有する医薬 |
| AU8355998A (en) | 1997-07-24 | 1999-02-16 | Yamanouchi Pharmaceutical Co., Ltd. | Medicinal compositions with cholesterol-lowering effect |
| GB9914977D0 (en) | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| GB0031107D0 (en) | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
| CN1543451A (zh) * | 2001-06-07 | 2004-11-03 | 过氧化物酶体增生剂激活的受体的调节剂 | |
| EP1414778A1 (en) | 2001-07-30 | 2004-05-06 | Novo Nordisk A/S | Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| WO2003016291A1 (en) | 2001-08-10 | 2003-02-27 | Nippon Chemiphar Co., Ltd. | ACTIVATOR FOR PEROXISOME PROLIFERATOR-RESPONSIVE RECEPTOR δ |
| MXPA04003398A (es) | 2001-10-12 | 2004-11-22 | Nippon Chemiphar Co | Activador para el receptor o activado con el proliferador de peroxisoma. |
| ITRM20020014A1 (it) | 2002-01-15 | 2003-07-15 | Sigma Tau Ind Farmaceuti | Derivati di acidi a-feniltiocarbossilici e a-fenilossicarbossilici utili per il trattamento di patologie che rispondono all'attivazione del |
| JP4383177B2 (ja) | 2002-03-01 | 2009-12-16 | スミスクライン ビーチャム コーポレーション | ｈＰＰＡＲ活性化剤 |
| US6875780B2 (en) * | 2002-04-05 | 2005-04-05 | Warner-Lambert Company | Compounds that modulate PPAR activity and methods for their preparation |
| GB0214149D0 (en) | 2002-06-19 | 2002-07-31 | Glaxo Group Ltd | Chemical compounds |
| CA2499380A1 (en) * | 2002-09-05 | 2004-03-18 | Novo Nordisk A/S | Novel vinyl carboxylic acid derivatives and their therapeutical use |
| KR20050061562A (ko) * | 2002-10-28 | 2005-06-22 | 노보 노르디스크 에이/에스 | 신규 화합물, 그들의 제제 및 사용 |
| DE60332860D1 (de) * | 2002-10-28 | 2010-07-15 | High Point Pharmaceuticals Llc | Neue verbindungen, die sich f r die behandlung von durch ppar vermittelten krankheiten eignen |
| PL378110A1 (pl) | 2003-02-14 | 2006-03-06 | Biogen Idec Ma Inc. | Kaseta ekspresyjna i wektor do przejściowej albo stabilnej ekspresji egzogennych cząsteczek |
| JP2007502815A (ja) * | 2003-08-20 | 2007-02-15 | イーライ リリー アンド カンパニー | Ｐｐａｒ調節因子 |
| UA87467C2 (xx) * | 2003-09-19 | 2009-07-27 | Янссен Фармацевтика Н.В | 4-((феноксіалкіл)тіо)феноксіоцтова кислота та її аналоги$4-((феноксиалкил)тио)феноксиуксусная кислота и ее аналоги |
| CA2539403C (en) * | 2003-09-19 | 2013-11-19 | Janssen Pharmaceutica N.V. | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| ATE362367T1 (de) | 2003-10-31 | 2007-06-15 | Janssen Pharmaceutica Nv | Phenoxyessigsäure-derivate als peroxisom- proliferator-aktivierte rezeptor (ppar) dual- agonisten |
| ATE461932T1 (de) | 2004-04-21 | 2010-04-15 | Schering Corp | Pyrazoloä4,3-eü-1,2,4-triazoloä1,5-cüpyrimidine als antagonisten des adenosin-a2a-rezeptors |
| CN1997619B (zh) * | 2004-07-01 | 2010-08-25 | 霍夫曼-拉罗奇有限公司 | 包含乙炔基的苯基衍生物 |
| MY145712A (en) | 2004-09-15 | 2012-03-30 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| MY147518A (en) * | 2004-09-15 | 2012-12-31 | Janssen Pharmaceutica Nv | 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs |
| PE20060664A1 (es) | 2004-09-15 | 2006-08-04 | Novartis Ag | Amidas biciclicas como inhibidores de cinasa |
| JO3006B1 (ar) * | 2005-09-14 | 2016-09-05 | Janssen Pharmaceutica Nv | املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك |
| GB0618963D0 (en) * | 2006-09-26 | 2006-11-08 | Ucl Business Plc | Formulations and composites with reactive fillers |
-
2006
- 2006-09-07 JO JOP/2006/0300A patent/JO3006B1/ar active
- 2006-09-13 TW TW095133769A patent/TWI414510B/zh active
- 2006-09-13 NZ NZ566504A patent/NZ566504A/en unknown
- 2006-09-13 DK DK06803483.4T patent/DK1937065T3/en active
- 2006-09-13 KR KR1020187018792A patent/KR20180079468A/ko not_active Ceased
- 2006-09-13 EP EP06803483.4A patent/EP1937065B1/en active Active
- 2006-09-13 PT PT06803483T patent/PT1937065E/pt unknown
- 2006-09-13 KR KR1020087008237A patent/KR20080046695A/ko not_active Ceased
- 2006-09-13 AR ARP060103994A patent/AR058044A1/es not_active Application Discontinuation
- 2006-09-13 HU HUE06803483A patent/HUE025185T2/en unknown
- 2006-09-13 PL PL06803483T patent/PL1937065T3/pl unknown
- 2006-09-13 JP JP2008531264A patent/JP5467770B2/ja active Active
- 2006-09-13 WO PCT/US2006/035617 patent/WO2007033231A2/en not_active Ceased
- 2006-09-13 PE PE2006001117A patent/PE20070434A1/es active IP Right Grant
- 2006-09-13 ES ES06803483.4T patent/ES2535427T3/es active Active
- 2006-09-13 SI SI200631916T patent/SI1937065T1/sl unknown
- 2006-09-13 CN CN2006800405764A patent/CN101304656B/zh active Active
- 2006-09-13 AU AU2006291006A patent/AU2006291006B2/en active Active
- 2006-09-13 BR BRPI0615835A patent/BRPI0615835B8/pt not_active IP Right Cessation
- 2006-09-13 KR KR1020167016579A patent/KR20160079129A/ko not_active Ceased
- 2006-09-13 CA CA2622722A patent/CA2622722C/en active Active
- 2006-09-13 KR KR1020157001219A patent/KR20150013952A/ko not_active Ceased
- 2006-09-13 US US11/531,464 patent/US7709682B2/en active Active
- 2006-09-13 KR KR1020137022058A patent/KR20130100800A/ko not_active Ceased
- 2006-09-14 GT GT200600420A patent/GT200600420A/es unknown
- 2006-09-14 UY UY29791A patent/UY29791A1/es not_active Application Discontinuation
- 2006-09-14 HN HN2006032171A patent/HN2006032171A/es unknown
-
2010
- 2010-03-18 US US12/726,457 patent/US8669288B2/en active Active
-
2025
- 2025-07-28 LU LU50018C patent/LUC50018I2/en unknown
- 2025-07-31 FI FIC20253005C patent/FIC20253005I1/fi unknown
- 2025-07-31 LT LTPA2025530C patent/LTC1937065I2/lt unknown
- 2025-08-01 BE BE2025C533C patent/BE2025C533I2/nl unknown
- 2025-08-05 FR FR25C1030C patent/FR25C1030I2/fr active Active
- 2025-08-13 NL NL301339C patent/NL301339I2/nl unknown
- 2025-08-13 HU HUS2500034C patent/HUS2500034I1/hu unknown
- 2025-08-13 CY CY2025023C patent/CY2025023I2/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2025023I1 (el) | Νεα αλατα λυσινης παραγωγων 4- ((φαινοξυαλκυλ)θειο)-φαινοξυοξεικου οξεος | |
| DK2173730T3 (da) | Hidtil ukendte forbindelser 951: biphenyloxypropansyre som crth2-modulator og mellemprodukter | |
| CY2021030I2 (el) | Νεο οξινο θειικο αλας | |
| DK2178840T3 (da) | Azabiphenylaminobenzoesyre-derivater som dhodh-hæmmere | |
| CU24179B1 (es) | SALES DE ÁCIDO MALEICO Y DE ÁCIDO SULFÚRICO DE (R)-3-(4-(7H-PIRROLO[2,3-d]PIRIMIDIN-4-IL)-1H-PIRAZOL-1-IL)-3-CICLOPENTILPROPANITRILO | |
| DK1660431T3 (da) | Phenoxyeddikesyrederivater | |
| DK2010496T3 (da) | 4-anilinoquinolin-3-carbonsyreamider som CSF-1R-kinaseinhibitorer | |
| SMT201600174B (it) | Forme solide di acido 3-(6-(1-(2,2-difluorobenzo[d][1,3]diossol-5-il)ciclopropancarbossammido)-3-metilpiridin-2-il)benzoico | |
| BRPI0918586A2 (pt) | compostos, composições e métodos de uso dos mesmos para a modulação dos níveis de ácido úrico | |
| DK1919865T3 (da) | 1-Heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-)aryl-substituerede 1-h-pyrrolderivater som syresekretionsinhibitorer | |
| ATE509925T1 (de) | Substituierte bicyclocarbonsäureamidverbindungen | |
| EP2367808A4 (en) | PROGESTATIVE 3- (6,6-ETHYLENE-17b-HYDROXY-3-OXO-17a-PREGNA-4-EN-17a-YL) PROPIONIC ACID g-LACTONE | |
| DE602006013513D1 (de) | Enzymatische herstellung von persäuren aus carbonsäureestersubstraten mittels nicht-häm-haloperoxidasen | |
| ATE530523T1 (de) | (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)- essigsäurederivate | |
| DK1860098T3 (da) | Nyt anthranilsyrderivat eller salt deraf | |
| DK1753760T3 (da) | 4-hydroxy-4-methyl-piperidin-1-carboxylsyre-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amid | |
| IL186852A0 (en) | Benzoic acid derivatives that are modulators or agonists of glyr | |
| DK1650186T3 (da) | Nye dicarboxylsyrederivater | |
| NO20081199L (no) | Tetraorganoammonium- og tetroorganofosfoniumsalter for syregass-skrubbeprosess | |
| PL382346A1 (pl) | Sposób wytwarzania soli sodowej kwasu 1-(((1(R)-(3-(2-(7--chloro-2- chinolinylo)-etenylo)fenylo)-3-(2-(1-hydroksy-1- metyloetylo)fenylo)propylo)sulfanylo)metylo)-cyklopropanooctowego | |
| ATE511837T1 (de) | Wässrige arzneimittelformulierung von 4-ä((4- carboxybutyl)-ä2-ä(4-phenethyl-benzyl)oxyü- phenethylüamino)methylübenzoesäure | |
| ATE526966T1 (de) | Flüssige formulierungen von salzen von 4-ä2-(4- methylphenylsulfanyl)phenylüpiperidin | |
| NO20084860L (no) | Stabile farmasøytiske preparater av 2-aza-bisyklo-[3,3,0]-oktan-3-karboksylsyrederivater | |
| NO20082973L (no) | Salter av styfninsyre | |
| DK2010538T3 (da) | Fremgangsmåde til fremstilling af [(1R), 2S]-2-aminopropionsyre 2-[4-(4-fluor-2-methyl-1H-indol-5-yloxy)-5-methylpyrrol]2,1-f-[1,2,4-triazin-6-yloxy]-1-methylethylester |